Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT01489670 · clinicaltrials.gov ↗
COMPLETED
Status
387
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan